Cadila Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Cadila Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011797
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cadila Pharmaceuticals Ltd (Cadila Pharmaceuticals) is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. The company’s products include active pharmaceutical ingredients (API) and pharmaceutical formulations. Its business includes contract research operation, contract manufacturing, herbal and agro divison. Cadila Pharmaceuticals products are used in the therapeutic areas of gastrointestinal, cardiovascular, anti-infectives and antibiotics, analgesics, haematinics, respiratory agents, immunologicals, oncology and antidiabetics, among others. The company’s products are in the form of capsules, tablets, orals, soft and hard gelatin capsules, and liquids. It has operations in Kenya, Nigeria, Ethiopia, the UK, Russia, the US, Sweden and Japan. Cadila Pharmaceuticals is headquartered in Ahmedabad, Gujarat, India.

Cadila Pharmaceuticals Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cadila Pharmaceuticals Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Aplagon Enters into Agreement with Cadila Pharma Sweden 11
Oncology Venture Enters into Co-Development Agreement with Cadila Pharma 12
Lipidor Enters into Agreement with Cadila Pharma 13
Axelar Enters into Co-Development Agreement with Cadila Pharma 14
Cadila Pharma Enters into Agreement with Respiratorius 15
NovaSAID Enters Into Co-Development Agreement With Cadila Pharma 16
Pergamum And Cadila Pharma Partner To Develop Novel Antibiotics For Infections 17
Licensing Agreements 18
Cadila Pharma and Altus Formulation Enter into Agreement 18
Cadila Pharma Enters into Licensing Agreement with Moberg Pharma 19
Cadila Pharma Enters Into Licensing Agreement With Helperby Therapeutics 20
Cadila Pharmaceuticals Ltd – Key Competitors 21
Cadila Pharmaceuticals Ltd – Key Employees 22
Cadila Pharmaceuticals Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 25
Legal and Regulatory 25
Sep 02, 2016: Cadila Healthcare Receives Establishment Inspection Report For Ahmedabad 25
Aug 16, 2016: Cadila Healthcare provides Operational Update 26
Aug 16, 2016: Cadila Healthcare Receives Establishment Inspection Report For Changodar Facility 27
Other Significant Developments 28
Mar 22, 2016: Cadila Healthcare: Corporate Announcement 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cadila Pharmaceuticals Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Cadila Pharmaceuticals Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aplagon Enters into Agreement with Cadila Pharma Sweden 11
Oncology Venture Enters into Co-Development Agreement with Cadila Pharma 12
Lipidor Enters into Agreement with Cadila Pharma 13
Axelar Enters into Co-Development Agreement with Cadila Pharma 14
Cadila Pharma Enters into Agreement with Respiratorius 15
NovaSAID Enters Into Co-Development Agreement With Cadila Pharma 16
Pergamum And Cadila Pharma Partner To Develop Novel Antibiotics For Infections 17
Cadila Pharma and Altus Formulation Enter into Agreement 18
Cadila Pharma Enters into Licensing Agreement with Moberg Pharma 19
Cadila Pharma Enters Into Licensing Agreement With Helperby Therapeutics 20
Cadila Pharmaceuticals Ltd, Key Competitors 21
Cadila Pharmaceuticals Ltd, Key Employees 22
Cadila Pharmaceuticals Ltd, Other Locations 23
Cadila Pharmaceuticals Ltd, Subsidiaries 23
Cadila Pharmaceuticals Ltd, Joint Venture 24

★海外企業調査レポート[Cadila Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Schlumberger N.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Schlumberger N.V. Mergers and A …
  • Atomenergoprom:企業の戦略的SWOT分析
    Atomenergoprom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Forbo Holding AG (FORN):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Forbo Holding AG" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows …
  • Buzzlogic, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Buzzlogic, Inc. Mergers and Acq …
  • Thermal Energy International, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Thermal Energy International, I …
  • Omnicom Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Omnicom Group, Inc. Mergers and …
  • Randgold Resources Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Randgold Resources Limited Merg …
  • Awilco LNG AS (ALNG):企業の財務及び戦略的SWOT分析
    Summary Awilco LNG ASA (Awilco LNG) is an oil and gas company that offers LNG transportation. The company owns and operates LNG vessels intended for international trade. Its LNG value chain includes production, liquefaction, transportation, regasification and offtake. Awilco LNG operates through it …
  • EOS GmbH Electro Optical Systems:企業の戦略・SWOT・財務分析
    SummaryEOS GmbH Electro Optical Systems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • Cal-Maine Foods, Inc. (CALM):企業の財務及び戦略的SWOT分析
    Summary Cal-Maine Foods, Inc. (Cal-Maine) is a producer and supplier of shell eggs that provides nutritionally enhanced cage free and organic eggs. The company's business includes production, grading, packaging, marketing and distribution of shell eggs. Its specialty shell eggs include nutritionally …
  • Zion Oil & Gas, Inc. (ZN):企業のM&A・提携動向(石油・ガス分野)
    Summary Zion Oil & Gas, Inc. (Zion) is an oil and gas company that explores and produces oil and gas properties. The company provides geological, geophysical and other science-based studies and other surveys to support its oil and gas exploration activities. It also holds petroleum exploration licen …
  • TRC Synergy Berhad:企業の戦略・SWOT・財務分析
    SummaryTRC Synergy Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Walker Greenbank PLC:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Walker Greenbank PLC" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly foll …
  • Gran Tierra Energy, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Gran Tierra Energy, Inc. Merger …
  • TELUS Corporation:企業のM&A・提携・投資分析
    TELUS Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TELUS Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • XL Group plc:企業の戦略・SWOT・財務分析
    SummaryXL Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Royal Coal Corp. (formerly Amalfi Capital Corporation):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Royal Coal Corp. (formerly Amal …
  • SBM Offshore N.V. (SBMO)(石油・ガス分野):企業M&A動向
    Summary SBM Offshore N.V. (SBM Offshore) is a floating production and mooring systems provider. The company designs supplies, installs and operates Floating Production, Storage and Offloading (FPSO) vessels. FPSO vessels owned and operated by the company are leased to its clients. It also undertakes …
  • Maxeda B.V.:企業の戦略・SWOT・財務分析
    SummaryMaxeda B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Standard Solar Inc:企業のM&A・提携動向(発電分野)
    Summary Standard Solar Inc (Standard Solar) is a renewable energy company that involves in financing, installing, developing and construction of solar electric systems. SSI provides energy assessment and green energy remodeling services. The company offers solutions that include rooftop, ground moun …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆